Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical desmopressin, phenylephrine and tranexamic acid for bleeding control in rhinoplasty
IRCT20240712062409N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jul 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in rhinoplasty and deviated nasal septum (DNS) comparing Topical desmopressin, Topical phenylephrine and Topical tranexamic acid (3 arms). Primary endpoints: Intraoperative blood loss volume and Surgeon’s visual field quality. Started Jul 2024; status: completed.
02
Drugs
desmopressinphenylephrinetranexamic acid
03
Conditions
rhinoplastydeviated nasal septum (DNS)
Beyond the preview
Go deeper on IRCT20240712062409N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240712062409N1.